Explore "oncolyticviraltherapy" with insightful episodes like "Improving Provider Confidence in Patient Identification and the Administration of Oncolytic Viral Therapy With Drs. Howard Kaufman and Anna Pavlick", "Mechanisms of Oncolytic Viral Therapy With Drs. Howard Kaufman and Kevin Harrington" and "Oncolytic Viral Therapy – A Look at the Latest Evidence With Drs. Howard Kaufman and Ann Silk" from podcasts like ""MedEdTalks - Oncology", "MedEdTalks - Oncology" and "MedEdTalks - Oncology"" and more!
Within this podcast, Improving Provider Confidence in Patient Identification and the Administration of Oncolytic Viral Therapy, Dr. Howard Kaufman and Dr. Anna C. Pavlick examine the patient and tumor characteristics that may make a patient with advanced melanoma a good candidate for oncolytic viral therapy with or without a checkpoint inhibitor.
Within this podcast, Mechanisms of Oncolytic Viral Therapy, Dr. Howard Kaufman and Professor Kevin Harrington review the rationale for the use of oncolytic viral therapies as monotherapy or in combination with checkpoint inhibitors for patients with advanced melanoma.
Within the podcast, Oncolytic Viral Therapy – A Look at the Latest Evidence, Dr. Howard Kaufman and Dr. Ann Silk assess the latest clinical evidence regarding available and emerging oncolytic viral therapies for the management of patients with advanced melanoma.
Stay up to date
For any inquiries, please email us at hello@podcastworld.io